1 / 16

Cervical Cancer Vaccines Market Analysis (2018-2026)

Read here the market research report on the u201cCervical Cancer Vaccines Market" published by CMI Team

kunalbhuta
Download Presentation

Cervical Cancer Vaccines Market Analysis (2018-2026)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. CERVICAL CANCER VACCINES MARKET ANALYSIS -(2018-2026) • Cervical Cancer Vaccines Market, By Product Type (Cervarix, Gardasil, and Gardasil 9), By Distribution Channel (Hospitals, Clinics, and Government Entities), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

  3. Cervical cancer is a common type of cancer occurring in women worldwide. A major cause of cervical cancer is infection by human papillomavirus (HPV), which is found in 99% cervical cancer. Human papillomavirus is sexually transmitted. Around 100 types of HPV have been identified to date, of which types 16 and 18 are believed to be responsible for more than 70% of cervical cancers. Cervarix and Gardasil are type of vaccines used for the treatment of cervical cancer.

  4. Market Dynamics • Increasing prevalence of cervical cancer worldwide is expected to boost the cervical cancer vaccines market growth. According to the World Health Organization (WHO), 2018, cervical cancer is the fourth most frequent cancer in women with an estimated 570,000 new cases and representing 6.6% of all female cancers worldwide and around 85% of deaths occur due to cervical cancer in developing countries. • However, lack of awareness amongst the people in the low-income and middle-income countries regarding cervical cancer is expected to hinder growth of the cervical cancer vaccines market during the forecast period. Cervical cancer is one of the most common cancers among women of reproductive age in low-income and middle-income countries. For instance, according to The International Agency for Research on Cancer’s (IARC) report of 2013, cervical cancer is most notable in low-income countries of sub-Saharan Africa.

  5. Key features of the study: • This report provides in-depth analysis of the global cervical cancer vaccines market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 – 2026, considering 2018 as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the cervical cancer vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

  6. Key players covered as a part of this study include, GlaxoSmithKline plc. and Merck & Co. Inc. • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics • The cervical cancer vaccines market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts

  7. Detailed Segmentation: • Global Cervical Cancer Vaccines Market , By Product Type: • Gardasil • Gardasil 9 • Cervarix • Global Cervical Cancer Vaccines Market, By Distribution Channel: • Hospitals • Clinics • Government Entities

  8. Global Cervical Cancer Vaccines Market, By Region: • North America • By Country: • U.S. • Canada • By Product Type: • Gardasil • Gardasil 9 • Cervarix • By Distribution Channel: • Hospitals • Clinics • Government Entities

  9. By Distribution Channel: • Hospitals • Clinics • Government Entities • Asia Pacific • By Country: • Australia • India • China • Japan • ASEAN • South Korea • Rest of Asia Pacific • Europe • By Country: • U.K. • Germany • Italy • Spain • France • Russia • Rest of Europe • By Product Type: • Gardasil • Gardasil 9 • Cervarix

  10. Latin America • By Country: • Brazil • Mexico • Argentina • Rest of Latin America • By Product Type: • Gardasil • Gardasil 9 • Cervarix • By Product Type: • Gardasil • Gardasil 9 • Cervarix • By Distribution Channel: • Hospitals • Clinics • Government Entities

  11. By Distribution Channel: • Hospitals • Clinics • Government Entities • Africa • By Country/Region: • South Africa • Central Africa • North Africa • By Product Type: • Gardasil • Gardasil 9 • Cervarix • ByDistribution Channel: • Hospitals • Clinics • Government Entities • Middle East • By Country: • GCC • Israel • Rest of Middle East • By Product Type: • Gardasil • Gardasil 9 • Cervarix

  12. Merck & Co. Inc. • Company Overview • Product Portfolio • Financial Performance • Recent Highlights • Strategies •  “*” marked represents similar segmentation in other categories in the respective section. • By Distribution Channel: • Hospitals • Clinics • Government Entities • Company Profiles • GlaxoSmithKline plc.* • Company Overview • Product Portfolio • Financial Performance • Recent Highlights • Strategies

  13. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference:https://www.coherentmarketinsights.com/market-insight/cervical-cancer-vaccines-market-2931

  14. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  15. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  16. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related